- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Par Drugs and Chemicals has announced a board meeting on 14th May to approve the financial results for the quarter and half-year. The company posted Q4 revenue of Rs. 22.33 Cr with a PAT of Rs. 1.65 Cr, backed by strong operational cash flows of Rs. 16.16 Cr for FY25. Standalone assets stood at Rs. 119.39 Cr with zero debt, highlighting a robust balance sheet. The Board approved a 10% bonus payout worth Rs. 23.79 lakh for employees, emphasizing workforce rewards. No dividend or fundraising plans were disclosed.